KFI
TEVA icon

Key Financial Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Key Financial Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-425
Closed -$3.43K – 1215
2022
Q4 		$3.43K Hold
425
– – ﹤0.01% 859
2022
Q3 		$3K Buy
425
+325
+325% +$2.87K ﹤0.01% 912
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1055
2022
Q1 		$1K Hold
100
– – ﹤0.01% 1039
2021
Q4 		$1K Hold
100
– – ﹤0.01% 923
2021
Q3 		$1K Hold
100
– – ﹤0.01% 888
2021
Q2 		$1K Hold
100
– – ﹤0.01% 835
2021
Q1 		$1K Hold
100
– – ﹤0.01% 747
2020
Q4 		$1K Buy
+100
New +$958 ﹤0.01% 694
2020
Q2 		– Sell
-100
Closed -$1K – 568
2020
Q1 		$1K Buy
+100
New +$1.02K ﹤0.01% 657

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Key Financial Inc's TEVA Position: Q1 2023 in Review

Key Financial Inc sold out of Teva Pharmaceuticals (TEVA) in Q1 2023, closing a stake of 425 shares — an estimated $3.43K sold.

Key Financial Inc first reported a position in TEVA in Q1 2020 and held it in 10 quarters. The position peaked at $3.43K in Q4 2022. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

  • Key Financial Inc reported no remaining Teva Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Key Financial Inc sold 425 Teva Pharmaceuticals shares in Q1 2023, an estimated $3.43K.
  • Key Financial Inc first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Key Financial Inc's Teva Pharmaceuticals position peaked at $3.43K in Q4 2022.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2023.

Based on Key Financial Inc's 13F filing for Q1 2023, filed 2 May 2023.